-transparent.png){kind=logo}
The new non-benzodiazepine hypnotic, zopiclone, was investigated as a preanaesthetic medication in a randomized, double-blind, placebo-controlled study in healthy patients scheduled for minor gynaecological surgery. Initially a dose-finding study was conducted in which zopiclone 3.75 mg, 7.5, and 11.25 mg was compared with diazepam 10 mg and placebo; 7.5 mg was established as the optimum dose of zopiclone. In the main study zopiclone 7.5 mg was comparable to diazepam 10 mg at 20, 40, and 60 min after administration and more efficacious at 90 min.
Related Publications
J W Dundee, and
R J Elwood, and
P J Hildebrand, and
M Singleton
April 1990,
International clinical psychopharmacology,
J W Dundee, and
R J Elwood, and
P J Hildebrand, and
M Singleton
October 2002,
Masui. The Japanese journal of anesthesiology,
J W Dundee, and
R J Elwood, and
P J Hildebrand, and
M Singleton
September 2010,
Journal of biopharmaceutical statistics,
J W Dundee, and
R J Elwood, and
P J Hildebrand, and
M Singleton
December 2001,
Biometrics,
J W Dundee, and
R J Elwood, and
P J Hildebrand, and
M Singleton
January 1983,
Pharmacology,
J W Dundee, and
R J Elwood, and
P J Hildebrand, and
M Singleton
January 1982,
International pharmacopsychiatry,
J W Dundee, and
R J Elwood, and
P J Hildebrand, and
M Singleton
April 1983,
NIDA research monograph,
J W Dundee, and
R J Elwood, and
P J Hildebrand, and
M Singleton
July 2022,
Biostatistics (Oxford, England),
J W Dundee, and
R J Elwood, and
P J Hildebrand, and
M Singleton
March 1994,
British journal of clinical pharmacology,
J W Dundee, and
R J Elwood, and
P J Hildebrand, and
M Singleton
April 2020,
Biostatistics (Oxford, England),
